Search Results - "Patrick Rampal"

Refine Results
  1. 1
  2. 2

    Saccharomyces boulardii modifies Salmonella typhimurium traffic and host immune responses along the intestinal tract by Pontier-Bres, Rodolphe, Munro, Patrick, Boyer, Laurent, Anty, Rodolphe, Imbert, Véronique, Terciolo, Chloé, André, Fréderic, Rampal, Patrick, Lemichez, Emmanuel, Peyron, Jean-François, Czerucka, Dorota

    Published in PloS one (13-08-2014)
    “…Salmonella enterica serovar Typhimurium (ST) is an enteropathogenic Gram-negative bacterium that causes infection following oral ingestion. ST spreads rapidly…”
    Get full text
    Journal Article
  3. 3

    Modification of Salmonella Typhimurium motility by the probiotic yeast strain Saccharomyces boulardii by Pontier-Bres, Rodolphe, Prodon, François, Munro, Patrick, Rampal, Patrick, Lemichez, Emmanuel, Peyron, Jean François, Czerucka, Dorota

    Published in PloS one (19-03-2012)
    “…Motility is an important component of Salmonella enterica serovar Typhimurium (ST) pathogenesis allowing the bacteria to move into appropriate niches, across…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Experimental effects of Saccharomyces boulardii on diarrheal pathogens by Czerucka, Dorota, Rampal, Patrick

    Published in Microbes and Infection (01-06-2002)
    “…Saccharomyces boulardii is a selected strain of yeast that may have applications in the prevention and treatment of intestinal infections. The animal models…”
    Get full text
    Book Review Journal Article
  6. 6

    Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells by Parassol, Nadège, Freitas, Miguel, Thoreux, Karine, Dalmasso, Guillaume, Bourdet-Sicard, Raphaelle, Rampal, Patrick

    Published in Research in microbiology (01-03-2005)
    “…Probiotics are living microorganisms which, when ingested in adequate amounts, exert health benefits toward the host. For instance, probiotics might act…”
    Get full text
    Journal Article
  7. 7

    Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections by Czerucka, Dorota, Rampal, Patrick

    Published in World journal of gastroenterology : WJG (14-05-2019)
    “…The yeast CNCM I-745 is one of the probiotics recommended for the prevention of antibiotic-associated diarrhea. Studies conducted and demonstrated that in the…”
    Get full text
    Journal Article
  8. 8

    Saccharomyces boulardii Interferes with Enterohemorrhagic Escherichia coli-Induced Signaling Pathways in T84 Cells by DAHAN, Stephanie, DALMASSO, Guillaume, IMBERT, Veronique, PEYRON, Jean-Francois, RAMPAL, Patrick, CZERUCKA, Dorota

    Published in Infection and Immunity (01-02-2003)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  9. 9

    The Saccharomyces boulardii CNCM I-745 strain shows protective effects against the B. anthracis LT toxin by Pontier-Bres, Rodolphe, Rampal, Patrick, Peyron, Jean-François, Munro, Patrick, Lemichez, Emmanuel, Czerucka, Dorota

    Published in Toxins (30-10-2015)
    “…The probiotic yeast Saccharomyces boulardii (S. boulardii) has been prescribed for the prophylaxis and treatment of several infectious diarrheal diseases…”
    Get full text
    Journal Article
  10. 10

    Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition by Schneider, Stephane-M, Girard-Pipau, Fernand, Filippi, Jerome, Hebuterne, Xavier, Moyse, Dominique, Hinojosa, Gustavo-Calle, Pompei, Anne, Rampal, Patrick

    Published in World journal of gastroenterology : WJG (21-10-2005)
    “…Diarrhea is a significant problem in patients on total enteral nutrition (TEN) and may involve changes in intestinal short chain fatty acids or microflora…”
    Get full text
    Journal Article
  11. 11

    Saccharomyces boulardii Preserves the Barrier Function and Modulates the Signal Transduction Pathway Induced in Enteropathogenic Escherichia coli-Infected T84 Cells by CZERUCKA, Dorota, DAHAN, Stephanie, MOGRABI, Baharia, ROSSI, Bernard, RAMPAL, Patrick

    Published in Infection and Immunity (01-10-2000)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  12. 12

    Enterohemorrhagic Escherichia coli Infection Induces Interleukin-8 Production via Activation of Mitogen-Activated Protein Kinases and the Transcription Factors NF-κB and AP-1 in T84 Cells by DAHAN, Stephanie, BUSUTTIL, Valere, IMBERT, Veronique, PEYRON, Jean-Francois, RAMPAL, Patrick, CZERUCKA, Dorota

    Published in Infection and Immunity (01-05-2002)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  13. 13

    Implication of Mitogen-Activated Protein Kinases in T84 Cell Responses to Enteropathogenic Escherichia coli Infection by CZERUCKA, Dorota, DAHAN, Stéphanie, MOGRABI, Baharia, ROSSI, Bernard, RAMPAL, Patrick

    Published in Infection and Immunity (01-03-2001)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  14. 14

    Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3',5'-cyclic monophosphate induction in intestinal cells by Czerucka, D, Roux, I, Rampal, P

    Published in Gastroenterology (New York, N.Y. 1943) (01-01-1994)
    “…The yeast Saccharomyces boulardii inhibits the secretion induced by cholera toxin (CT) in rat jejunum. The present study was aimed at unraveling the mechanism…”
    Get more information
    Journal Article
  15. 15

    Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation: Epidemiological study in an unselected population by CAROLI-BOSC, Francois-Xavier, LE GALL, Philippe, PUGLIESE, Pascal, DELABRE, Benoit, CAROLI-BOSC, Corinne, DEMARQUAY, Jean-Francois, DELMONT, Jean-Pierre, RAMPAL, Patrick, MONTET, J. C

    Published in Digestive diseases and sciences (01-03-2001)
    “…Fibrate derivatives and HMG-CoA reductase inhibitors modify homeostasis of cholesterol. The aim of this study was to assess in an unselected population whether…”
    Get full text
    Conference Proceeding Journal Article
  16. 16
  17. 17

    Saccharomyces boulardii Does Not Prevent Relapse of Crohn's Disease by Bourreille, Arnaud, Cadiot, Guillaume, Le Dreau, Gérard, Laharie, David, Beaugerie, Laurent, Dupas, Jean–Louis, Marteau, Philippe, Rampal, Patrick, Moyse, Dominique, Saleh, Ashraf, Le Guern, Marie–Emmanuelle, Galmiche, Jean–Paul

    Published in Clinical gastroenterology and hepatology (01-08-2013)
    “…Background & Aims Saccharomyces boulardii is a probiotic yeast that has been shown to have beneficial effects on the intestinal epithelial barrier and…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Low risk of irritable bowel syndrome after Clostridium difficile infection by Piche, T, Vanbiervliet, G, Pipau, F Girard, Dainese, R, Hébuterne, X, Rampal, P, Collins, S M

    Published in Canadian journal of gastroenterology (01-11-2007)
    “…The incidence of postinfectious irritable bowel syndrome (IBS) ranges between 4% and 32% of individuals after bacterial or parasitic infection. This study…”
    Get full text
    Journal Article